130 related articles for article (PubMed ID: 36318495)
1. Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma.
Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
J Ocul Pharmacol Ther; 2023; 39(1):63-69. PubMed ID: 36318495
[No Abstract] [Full Text] [Related]
2. Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis.
Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
Jpn J Ophthalmol; 2021 Sep; 65(5):591-597. PubMed ID: 34283308
[TBL] [Abstract][Full Text] [Related]
3. Changes in Prostaglandin-associated Periorbital Syndrome After Switch from Conventional Prostaglandin F2α Treatment to Omidenepag Isopropyl in 11 Consecutive Patients.
Nakakura S; Terao E; Fujisawa Y; Tabuchi H; Kiuchi Y
J Glaucoma; 2020 Apr; 29(4):326-328. PubMed ID: 31913226
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
[TBL] [Abstract][Full Text] [Related]
5. Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.
Sakata R; Shirato S; Miyata K; Aihara M
Eye (Lond); 2014 Dec; 28(12):1446-51. PubMed ID: 25233818
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
[TBL] [Abstract][Full Text] [Related]
7. FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.
Sharif NA; Odani-Kawabata N; Lu F; Pinchuk L
Exp Eye Res; 2023 Apr; 229():109415. PubMed ID: 36803996
[TBL] [Abstract][Full Text] [Related]
8. One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl.
Oogi S; Nakakura S; Terao E; Fujisawa Y; Tabuchi H; Kiuchi Y
Cureus; 2020 Aug; 12(8):e10064. PubMed ID: 33005498
[TBL] [Abstract][Full Text] [Related]
9. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
Inoue K; Shiokawa M; Wakakura M; Tomita G
J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
[TBL] [Abstract][Full Text] [Related]
10. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
[TBL] [Abstract][Full Text] [Related]
11. Periorbital changes associated with prostaglandin analogs in Korean patients.
Kim HW; Choi YJ; Lee KW; Lee MJ
BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077
[TBL] [Abstract][Full Text] [Related]
12. Proposal of a simple grading system integrating cosmetic and tonometric aspects of prostaglandin-associated periorbitopathy.
Tanito M; Ishida A; Ichioka S; Takayanagi Y; Tsutsui A; Manabe K; Shirakami T; Sugihara K; Matsuo M
Medicine (Baltimore); 2021 Aug; 100(34):e26874. PubMed ID: 34449456
[TBL] [Abstract][Full Text] [Related]
13. Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy.
Skorin L; Dailey KH
Optom Vis Sci; 2016 Jul; 93(7):779-81. PubMed ID: 27055061
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study.
Nakakura S; Kanamori A; Fukuma Y; Wakabayashi S; Nagata Y; Adachi M
BMJ Open; 2021 Jan; 11(1):e040301. PubMed ID: 33514572
[TBL] [Abstract][Full Text] [Related]
15. Newly or switching effect of a selective EP2 agonist on intraocular pressure in Japanese patients with open-angle glaucoma.
Ueda K; Sakata R; Fujishiro T; Honjo M; Shirato S; Aihara M
Jpn J Ophthalmol; 2022 Sep; 66(5):434-439. PubMed ID: 35906503
[TBL] [Abstract][Full Text] [Related]
16. Lower Eyelid Horizontal Tightening in Prostaglandin Associated Periorbitopathy.
Procianoy F; P L Lang M; J L Bocaccio F
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S76-S79. PubMed ID: 32890116
[TBL] [Abstract][Full Text] [Related]
17. Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.
Sakata R; Shirato S; Miyata K; Aihara M
Jpn J Ophthalmol; 2014 Mar; 58(2):212-7. PubMed ID: 24390604
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid receptor agonists for glaucoma treatment.
Aihara M
Jpn J Ophthalmol; 2021 Sep; 65(5):581-590. PubMed ID: 34228229
[TBL] [Abstract][Full Text] [Related]
19. Adverse periocular reactions to five types of prostaglandin analogs.
Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin-associated periorbitopathy in latanoprost users.
Nakakura S; Yamamoto M; Terao E; Nagatomi N; Matsuo N; Fujisawa Y; Fujio Y; Tabuchi H; Kiuchi Y
Clin Ophthalmol; 2015; 9():51-6. PubMed ID: 25565768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
